Home › Funds › Invenomic Capital Management LP › EGO
Invenomic Capital Management LP position in EGO
ELDORADO GOLD CORP NEW · Materials
Invenomic Capital Management LP reported holding 1,157,819 shares of EGO (ELDORADO GOLD CORP NEW) in its Q2 2026 13F filing — a position valued at US$36.0M, representing 2.15% of its reported portfolio and ranking #10 among its reported holdings. Invenomic Capital Management LP has disclosed EGO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Invenomic Capital Management LP's EGO position evolved
Invenomic Capital Management LP first disclosed a stake in EGO in Q3 2023 at 2,289,734 shares (US$20.4M). The position peaked in Q3 2025 at 1,879,102 shares, worth US$54.3M. Across 12 filings, Invenomic Capital Management LP increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,157,819 shares valued at US$36.0M — a reduction of -276,055 shares quarter over quarter.. Notable position changes include a 41% trim in Q4 2023 (shares rose 8% over the following quarter), a 30% trim in Q3 2024 (shares fell 14% over the following quarter), a 127% increase in Q1 2025 (shares rose 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.29M | $20.40M | New |
| Q4 2023 | 1.36M | $17.60M | Reduce |
| Q1 2024 | 1.74M | $24.45M | Add |
| Q2 2024 | 1.64M | $24.32M | Reduce |
| Q3 2024 | 1.15M | $20.00M | Reduce |
| Q4 2024 | 995.85K | $14.81M | Reduce |
| Q1 2025 | 2.26M | $38.05M | Add |
| Q2 2025 | 2.03M | $41.33M | Reduce |
| Q3 2025 | 1.88M | $54.29M | Reduce |
| Q4 2025 | 1.50M | $53.75M | Reduce |
| Q1 2026 | 1.43M | $49.22M | Reduce |
| Q2 2026 | 1.16M | $36.00M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EGO and 13F data
EGO (ELDORADO GOLD CORP NEW) is a Materials company. 40 other funds we track also report a position in EGO — the largest reported positions include VAN ECK ASSOCIATES CORP (US$580.7M), L1 Capital Pty Ltd (US$448.2M), FAIRFAX FINANCIAL HOLDINGS LTD/ CAN (US$427.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EGO
- VAN ECK ASSOCIATES CORP 18.68M sh · $580.74M · Q2 2026
- L1 Capital Pty Ltd 14.42M sh · $448.24M · Q2 2026
- FAIRFAX FINANCIAL HOLDINGS LTD/ CAN 13.75M sh · $427.00M · Q2 2026
- Helikon Investments Ltd 11.18M sh · $347.59M · Q2 2026
- DONALD SMITH & CO., INC. 8.77M sh · $272.58M · Q2 2026
- Carrhae Capital LLP 3.91M sh · $121.54M · Q2 2026
- TT International Asset Management LTD 2.67M sh · $82.90M · Q2 2026
- SPROTT INC. 1.90M sh · $59.00M · Q2 2026
- ANTIPODES PARTNERS Ltd 1.68M sh · $52.18M · Q2 2026
- Cape Ann Asset Management Ltd 933.07K sh · $29.01M · Q2 2026
More on Invenomic Capital Management LP
FAQ
How long has Invenomic Capital Management LP held EGO?
Invenomic Capital Management LP has disclosed EGO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Invenomic Capital Management LP's current position in EGO?
As of Q2 2026, Invenomic Capital Management LP holds 1.16M shares of EGO (ELDORADO GOLD CORP NEW), valued at $36.00M, representing 2.15% of its reported portfolio and ranking #10.
Has Invenomic Capital Management LP been buying or selling EGO?
In the latest 13F filing (Q2 2026), Invenomic Capital Management LP reduced its position in EGO. The position peaked in Q3 2025 at 1.88M shares.
Which other funds hold EGO?
Other major institutional holders of EGO include VAN ECK ASSOCIATES CORP, L1 Capital Pty Ltd, FAIRFAX FINANCIAL HOLDINGS LTD/ CAN, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.